United Therapeutics Corporation
US ˙ NasdaqGS ˙ US91307C1027

SecurityUTHR / United Therapeutics Corporation
InstitutionTd Asset Management Inc
Latest Disclosed Ownership104,588 shares
Latest Disclosed Value $ 62,018,592
Td Asset Management Inc reports 7.55% decrease in ownership of UTHR / United Therapeutics Corporation

On May 11, 2026 - Td Asset Management Inc filed a 13F-HR form disclosing ownership of 104,588 shares of United Therapeutics Corporation (US:UTHR) valued at $62,018,592 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 113,135 shares of United Therapeutics Corporation. This represents a change in shares of -7.55% during the quarter. The current value of the position is $57,509,804 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 104,588 -8,547 -7.55 62,019 12.50 0.0269
2026-02-10 2025-12-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 113,135 -25,724 -18.53 55,125 -5.30 0.0443
2025-11-10 2025-09-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 138,859 6,581 4.98 58,211 53.15 0.0473
2025-07-28 2025-06-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 132,278 -15,633 -10.57 38,010 -16.64 0.0324
2025-05-07 2025-03-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 147,911 -2,543 -1.69 45,597 -14.11 0.0420
2025-02-11 2024-12-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 150,454 8,088 5.68 53,086 4.00 0.0470
2024-11-01 2024-09-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 142,366 28,584 25.12 51,042 40.82 0.0450
2024-08-02 2024-06-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 113,782 32,245 39.55 36,245 93.51 0.0338
2024-05-08 2024-03-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 81,537 -1,414 -1.70 18,731 2.69 0.0174
2024-02-12 2023-12-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 82,951 75,839 1,066.35 18,240 1,035.74 0.0179
2023-10-27 2023-09-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 7,112 3,750 111.54 1,606 116.44 0.0019
2023-08-09 2023-06-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 3,362 49 1.48 742 0.13 0.0008
2023-05-10 2023-03-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 3,313 3,313 742 0.0009
2023-02-06 2022-12-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 0 -52,611 -100.00 0 -100.00
2022-11-07 2022-09-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 52,611 -4,628 -8.09 10,940 -18.89 0.0137
2022-08-04 2022-06-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 57,239 16,498 40.49 13,488 84.54 0.0156
2022-05-10 2022-03-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 40,741 2 0.00 7,309 -16.97 0.0043
2022-02-10 2021-12-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 40,739 40,739 8,803 0.0074
2021-08-11 2021-06-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 0 -19,637 -100.00 0 -100.00
2021-05-14 2021-03-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 19,637 8,937 83.52 3,285 102.28 0.0037
2021-02-16 2020-12-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 10,700 10,700 1,624 0.0020
2020-08-13 2020-06-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 0 -11,800 -100.00 0 -100.00
2020-05-15 2020-03-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 11,800 11,800 1,119 0.0019
2017-08-01 2017-06-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 0 -33,178 -100.00 0 -100.00
2017-05-05 2017-03-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 33,178 -40 -0.12 4,492 -5.71 0.0072
2017-02-08 2016-12-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 33,218 30,781 1,263.07 4,764 1,554.17 0.0080
2016-11-02 2016-09-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 2,437 -713 -22.63 288 -13.77 0.0005
2016-08-04 2016-06-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 3,150 350 12.50 334 7.05 0.0006
2016-05-05 2016-03-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 2,800 100 3.70 312 -26.24 0.0006
2016-02-04 2015-12-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 2,700 -23,300 -89.62 423 -87.60 0.0008
2015-11-12 2015-09-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 26,000 -4,000 -13.33 3,412 -34.62 0.0067
2015-08-11 2015-06-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 30,000 1,100 3.81 5,219 4.74 0.0093
2015-04-28 2015-03-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 28,900 28,900 0.00 4,983 0.0090
2015-01-30 2014-12-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 0 -23,000 -100.00 0 -100.00
2014-11-06 2014-09-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 23,000 -1,500 -6.12 2,959 36.49 0.0051
2014-08-12 2014-06-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 24,500 -1,300 -5.04 2,168 -10.63 0.0037
2014-05-09 2014-03-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 25,800 12,300 91.11 2,426 58.87 0.0044
2014-02-07 2013-12-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 13,500 6,800 101.49 1,527 189.20 0.0029
2013-11-08 2013-09-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 6,700 400 6.35 528 27.23 0.0010
2013-07-24 2013-06-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 6,300 6,300 415 0.0009
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.